|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.08 USD | -0.67% |
|
-4.82% | -1.67% |
| May. 29 | Haemonetics Insider Sold Shares Worth $1,144,208, According to a Recent SEC Filing | MT |
| May. 29 | Haemonetics Insider Sold Shares Worth $775,253, According to a Recent SEC Filing | MT |
Haemonetics Corporation reported earnings results for the full year ended March 30, 2024. For the full year, the company reported sales was USD 1,309.06 million compared to USD 1,168.66 million a year ago. Net income was USD 117.56 million compared to USD 115.4 million a year ago.
Diluted earnings per share from continuing operations was USD 2.29 compared to USD 2.24 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.67% | 4.27B | |
| -7.16% | 178B | |
| -1.23% | 107B | |
| -4.86% | 67.04B | |
| -4.28% | 47.24B | |
| +10.32% | 44.62B | |
| +8.14% | 42.5B | |
| +15.76% | 29.99B | |
| +15.53% | 25.22B | |
| -5.88% | 24.14B |
HAEMONETICS CORPORATION 
